查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1808430

內視鏡黏膜下剝離術市場（依產品、手術類型、適應症類型、疾病狀況及最終使用者類型）－2025-2030 年全球預測

Endoscopic Submucosal Dissection Market by Product, Procedure Type, Indication Type, Disease Condition, End-User Type - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

內視鏡黏膜下剝離術市場規模預計在 2024 年達到 4.1294 億美元，在 2025 年達到 4.366 億美元，在 2030 年達到 5.8388 億美元，複合年成長率為 5.94%。

主要市場統計數據
基準年2024年 4.1294億美元
預計2025年 4.366億美元
預計2030年 5.8388億美元
複合年成長率（%） 5.94%

內視鏡黏膜下剝離術 (ESD) 是微創胃腸道治療的突破，最初在東亞地區率先推廣，但在西方市場逐漸被接受。此技術能夠對黏膜下層的早期腫瘤病變進行整塊切除，從而最佳化組織病理學評估，同時最大限度地降低手術創傷。 ESD 無與倫比的精準度已得到臨床界的認可，使其成為治療早期胃腸道癌症和某些癌前腫瘤的關鍵。內視鏡成像、整合電外科系統和內視鏡可操作性等現代技術的進步，顯著提高了該手術的安全性，並將其治療適應症擴展到最初的胃腸道疾病之外。

隨著技術的成熟，胃腸外科、腫瘤外科和生物醫學工程等跨學科專業知識的整合，推動了器材設計和操作人員能力的不斷提升。卓越中心如今已常規整合基於模擬的訓練模組、監考系統和結果登記系統，以簡化學習曲線並標準化臨床通訊協定。這個協作框架加速了ESD的全球應用，使ESD從利基創新發展成為先進治療性內視鏡技術的基石。在此背景下，包括醫療服務、設備製造和報銷機構在內的相關人員持續協調，在臨床有效性、手術成本控制和患者可及性方面取得平衡。

透過技術創新、培訓和以患者為中心的方法揭示內視鏡黏膜下剝離術的模式轉移

在器械和診斷成像技術不斷創新的推動下，內視鏡黏膜下剝離術（NES）的領域正在經歷模式轉移。近期，手術刀技術的改進，例如絕緣尖端、雙尖端和三角尖端設計，顯著提高了切除精度，同時降低了黏膜下穿孔的風險。同時，高清內視鏡視覺化技術與窄帶成像和共聚焦雷射內視鏡即時組織表徵的結合，使臨床醫生能夠以前所未有的精度描繪病變邊界。這些技術進步，加上輔助病變分割和電外科參數最佳化的人工智慧決策支援系統，正在從根本上改變手術的工作流程和療效。

2025年美國設備採購關稅調整及其對臨床可近性的影響

2025年，美國針對內視鏡黏膜下剝離術（ETS）所需的進口醫療設備及輔助零件實施了一系列關稅調整。這些調整給整個供應鏈帶來了微妙的成本壓力，尤其對先進的電外科刀、專用充氣裝置和高解析度內視鏡而言。為了減輕到岸成本上升的影響，醫院和門診中心正在評估採購慣例實踐的策略轉變，包括供應商多元化和積極的合約重新談判。同時，製造商正在重新評估其供應鏈配置，探索近岸外包機會，並最佳化零件採購，以保持競爭性價格，並確保臨床醫生能夠繼續使用尖端設備。

依產品技術、治療方式、臨床指徵、疾病狀態及最終用戶通路細分市場

內視鏡黏膜下剝離術市場可以透過檢視附件設備和核心內視鏡系統的產品創新來細分。配件設備包括帽子和罩、鉗子和夾、注射器針頭、氣腹裝置、各種刀型以及套管針。就刀類而言，雙刀、軟性刀、鉤刀、絕緣尖頭和三角尖頭器械具有獨特的性能特點，可根據特定的組織紋理和病變形態進行客製化。內視鏡系統進一步細分為大腸鏡、十二指腸鏡和胃鏡，每個系統都體現了獨特的人體工學和光學配置，這些配置會影響操作效率和臨床醫生的偏好。

揭示全球市場的區域採用模式、報銷框架與創新軌跡

在美洲，強大的醫療基礎設施和完善的報銷體系為內視鏡黏膜下剝離術的推廣奠定了堅實的基礎。美國和加拿大的卓越中心在手術量方面處於領先地位，並發表了關鍵的臨床證據，增強了相關人員的信心。支持先進內視鏡干預措施的政策環境使支付方能夠認知到微創病變切除帶來的長期成本節約，從而推動患者獲得治療機會並推動機構對尖端設備的投資。

塑造永續發展教育生態系統的相關人員的競爭格局和策略行動

內視鏡黏膜下剝離術 (EMS) 市場的競爭由全球醫療技術領導者和專業創新者主導。現有企業正在透過產品改進、獲得先進刀形和人體工學內視鏡設計的智慧財產權以及利用全球分銷網路滲透市場來增強其產品組合。同時，敏捷的新興企業正透過引入人工智慧輔助病變檢測軟體和旨在簡化手術流程的下一代氣腹技術，獲得關注。

積極的策略和協作努力推動創新、市場滲透和永續成長

為了抓住內視鏡黏膜下剝離術蓬勃發展的機遇，產業領導者必須重視跨職能夥伴關係，以整合臨床、監管和商業方面的專業知識。優先投資研發具有自適應回饋機制的下一代電外科手術刀，將有助於實現產品差異化，並應對不斷變化的臨床挑戰。同時，建立一個整合虛擬實境模擬器和認證監考的綜合培訓生態系統，將確保始終如一的手術質量，並縮短新興市場的採用曲線。

嚴謹的多模態研究框架，整合了原始研究、二手資料和分析三角測量

本執行執行摘要所依據的研究嚴格結合了主要研究方法和次要研究方法。關鍵意見領袖和內視鏡專家參與了結構化訪談和諮詢研討會，以深入觀點內視鏡黏膜下剝離術的臨床工作流程、技術應用障礙和未滿足的需求。這些定性見解也輔以對同行評審期刊、臨床試驗註冊中心和會議論文的廣泛查閱，以檢驗不斷發展的最佳實踐和新興的設備性能數據。

整合核心洞察與未來發展軌跡，賦能決策者，培養市場領導力

本執行摘要揭示了技術創新、監管變化和市場動態之間複雜的相互作用，這些因素共同塑造了內視鏡黏膜下剝離術領域。關鍵要點強調了先進的手術刀設計、增強的顯像模式以及人工智慧決策支援工具對手術有效性和安全性的重大影響。同時，價格調整和不斷變化的報銷格局的影響需要靈活的籌資策略和積極主動的相關人員參與。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章市場動態

  • 擴展水刀和混合刀技術，以便在 ESD 期間更快、更安全地切除病變
  • 將人工智慧驅動的病變識別系統引入內視鏡黏膜下剝離術的工作流程
  • 開發一種可在ESD手術中同時進行切開和穩定止血的多功能內視鏡刀
  • 推出一次性內視鏡平台，降低黏膜下層剝離過程中交叉污染的風險
  • 高解析度 3D 成像和擴增實境疊加整合，可精確定位 ESD 病變
  • 基於虛擬實境的ESD培訓模擬程序的成長將提高亞太市場醫生的熟練程度
  • 醫療設備製造商與學術中心夥伴關係，對新型 ESD 牽引裝置進行臨床檢驗
  • 下一代內視鏡注射液獲得監管部門核准，可增強黏膜下提升和手術效率
  • 使用夾線系統的牽引輔助 ESD 技術的使用增加，從而減少了手術時間和併發症。
  • 加強報銷政策，支持先進醫療保健系統的門診治療

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

8. 內視鏡黏膜下剝離術市場（依產品）

  • 附屬設備
    • 帽子和兜帽
    • 鑷子和夾子
    • 針頭
    • 吸入裝置
    • 刀
      • 雙重的
      • 彈性
      • 鉤
      • 帶絕緣尖端
      • 三角形尖端
    • 套管針
  • 內視鏡設備
    • 大腸鏡檢查
    • 十二指腸鏡
    • 胃鏡

9. 內視鏡黏膜下剝離術市場（依手術類型）

  • 全層切除術
  • 混合 ESD
  • 部分厚度切除術

第 10 章內視鏡黏膜下剝離術市場（依適應症類型）

  • 大腸直腸癌
  • 食道癌
  • 胃癌

11. 內視鏡黏膜下剝離術市場（依疾病狀況）

  • 良性腫瘤
  • 惡性腫瘤
    • 侵入性
    • 非侵入性

第 12 章內視鏡黏膜下剝離術市場（依最終使用者類型）

  • 門診手術中心
  • 醫院
  • 專科診所

13.美洲內視鏡黏膜下剝離術市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

14. 歐洲、中東和非洲內視鏡黏膜下剝離術市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

15. 亞太地區內視鏡黏膜下剝離術市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第16章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Ambu A/S
    • Beijing ZKSK Technology Co., Ltd.
    • Boston Scientific Corporation
    • ConMed Corporation
    • Erbe Elektromedizin GmbH
    • Fujifilm Holdings Corporation
    • Hoya Corporation
    • Huger Medical Instrument Co., Ltd.
    • Interscope, Inc.
    • Jiangsu Vedkang Medical Science and Technology Co., Ltd.
    • Karl Storz SE & Co. KG
    • Leo Medical Co. Ltd.
    • Medi-Globe GmbH by DCC Healthcare
    • Medtronic PLC
    • Micro-Tech Endoscopy
    • Mizuho America, Inc.
    • MTW-Endoskopie W. Haag KG
    • Olympus Corporation
    • Ovesco Endoscope AG
    • Richard Wolf GmbH
    • SonoScape Medical Corp.
    • Steris Corporation
    • Zeon Medical Inc.
    • Sumitomo Bakelite Co., Ltd.

第17章 研究人工智慧

第18章 研究統計

第19章 研究聯絡人

第20章 研究報導

第21章 附錄

Product Code: MRR-F611BFBC6402

The Endoscopic Submucosal Dissection Market was valued at USD 412.94 million in 2024 and is projected to grow to USD 436.60 million in 2025, with a CAGR of 5.94%, reaching USD 583.88 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 412.94 million
Estimated Year [2025] USD 436.60 million
Forecast Year [2030] USD 583.88 million
CAGR (%) 5.94%

Endoscopic Submucosal Dissection (ESD) emerged as a groundbreaking advancement in minimally invasive gastrointestinal interventions, initially pioneered in East Asia and progressively embraced by Western markets. This technique offers the capacity to achieve en bloc resection of early-stage neoplastic lesions within the submucosal layer, thereby minimizing procedural invasiveness while optimizing histopathological assessment. The clinical community has recognized ESD for its unparalleled precision, making it indispensable for managing early gastrointestinal cancers and select premalignant conditions. Contemporary enhancements in endoscopic imaging, electrosurgical system integration, and scope maneuverability have collectively elevated procedural safety profiles and expanded therapeutic indications beyond the initial gastric focus.

As the technology matures, a convergence of multidisciplinary expertise spanning gastroenterology, surgical oncology, and biomedical engineering has driven iterative improvements in instrument design and operator competency. Centers of excellence now routinely incorporate simulation-based training modules, proctorship programs, and outcome registries to streamline learning curves and standardize clinical protocols. These collaborative frameworks have accelerated global adoption, enabling ESD to transition from a niche innovation to a cornerstone in advanced therapeutic endoscopy. Against this backdrop, stakeholders across healthcare delivery, device manufacturing, and reimbursement agencies continue to navigate the balance between clinical efficacy, procedural cost containment, and broadening patient access.

Unveiling the Paradigm Shifts Reshaping Endoscopic Submucosal Dissection Through Innovation, Training, and Patient-Centered Approaches

The landscape of Endoscopic Submucosal Dissection is undergoing a paradigm shift driven by relentless innovation in instrumentation and imaging modalities. Recent refinements in knife technology, including insulation-tipped, dual, and triangle-tipped designs, have significantly enhanced resection precision while mitigating the risk of submucosal perforation. Simultaneously, the integration of high-definition endoscopic visualization and real-time tissue characterization through narrow-band imaging and confocal laser endomicroscopy has empowered clinicians to delineate lesion boundaries with unprecedented accuracy. These technological leaps are complemented by AI-enabled decision support systems that assist in lesion segmentation and electrosurgical parameter optimization, fundamentally altering procedural workflows and outcomes.

Equally transformative are the evolving training paradigms that prioritize competency-based progression and simulation-driven skill acquisition. Virtual reality simulators and ex vivo tissue models now replicate the tactile nuances of tissue dissection, allowing trainees to refine hand-eye coordination and complication management in a risk-free environment. Moreover, cross-institutional mentorship networks and teleproctoring platforms have democratized access to expert guidance, accelerating proficiency in regions previously limited by resource constraints. As a result, procedural adoption curves are flattening, and the global clinician community is advancing toward standardized ESD curricula anchored in rigorous outcome metrics. Collectively, these shifts underscore a patient-centered ethos that prioritizes safety, efficiency, and equitable access as the cornerstones of the next generation of GI therapeutic endoscopy.

Implications of 2025 U.S. Tariff Adjustments on Device Procurement and Clinical Accessibility

In 2025, the United States enacted a series of tariff modifications targeting imported medical devices and accessory components integral to endoscopic submucosal dissection. These adjustments have introduced nuanced cost pressures across the supply chain, particularly for advanced electrosurgical knives, specialized insufflation units, and high-definition endoscopes. Hospitals and outpatient centers are assessing strategic pivots in procurement practices, including supplier diversification and proactive contract renegotiations to mitigate the impact of increased landed costs. Concurrently, manufacturers are reevaluating supply chain configurations, exploring nearshoring opportunities, and optimizing component sourcing to preserve competitive pricing and maintain clinician access to state-of-the-art equipment.

Beyond immediate cost considerations, the tariff landscape is influencing broader research and development priorities. Device innovators are accelerating the design of modular systems that utilize locally sourced components and refining manufacturing processes to reduce dependency on tariff-affected imports. Health systems are likewise undertaking comprehensive budget impact analyses to balance capital expenditures against long-term clinical benefits, with an emphasis on value-based procurement policies. These strategic responses are reshaping the interplay between cost containment and clinical innovation, ultimately defining new benchmarks for market resilience and operational agility in the ESD space.

Deconstructing Market Segmentations Across Product Technologies, Procedure Modalities, Clinical Indications, Pathological Conditions, and End-User Channels

The endoscopic submucosal dissection market can be deconstructed by examining product innovations across accessory devices and core endoscopy systems. Accessory devices encompass items such as cap and hood assemblies, forceps and clips, injection needles, insufflation units, various knife subtypes, and trocars. Within the knife category itself, dual, flex, hook, insulation-tipped, and triangle-tipped instruments delineate performance attributes tailored to specific tissue textures and lesion topographies. Endoscopy systems further subdivide into colonoscopes, duodenoscopes, and gastroscopes, each embodying unique ergonomic and optical configurations that influence procedural efficiency and clinician preference.

Procedural modalities range from full-thickness resection techniques that enable complete transmural excision to hybrid approaches that integrate submucosal tunneling with en bloc removal, as well as partial-thickness resections optimized for discrete lesions. These variants have demonstrated varying risk-benefit profiles, informing institutional adoption based on tumor characteristics and operator proficiency. Clinical indications driving ESD adoption include colorectal, esophageal, and gastric cancer, reflecting the epidemiological burden of early-stage neoplastic presentations. Parallel to indication-based segmentation is the classification by disease condition, distinguishing benign tumors from malignant tumors and further stratifying malignant cases into invasive and non-invasive categories. This granularity informs both technology utilization and outcome expectations.

Finally, end-user channels span ambulatory surgical centers, hospitals, and specialty clinics, each presenting distinct procedural volumes, reimbursement frameworks, and investment capacities. Ambulatory surgical centers are gaining traction as efficient venues for straightforward ESD procedures, while tertiary hospitals continue to anchor complex cases and training initiatives. Specialty clinics focused on advanced endoscopy further contribute to the diffusion of technique-specific expertise and high-acuity patient management.

Illuminating Regional Adoption Patterns, Reimbursement Frameworks, and Innovation Trajectories Across Global Markets

In the Americas, robust healthcare infrastructures and well-established reimbursement systems underpin a strong base for endoscopic submucosal dissection adoption. Centers of excellence across the United States and Canada lead in procedural volumes and publish pivotal clinical evidence, reinforcing stakeholder confidence. Policy environments that support advanced endoscopic interventions have enabled payers to recognize the long-term cost savings associated with minimally invasive lesion removal, thereby fostering patient access and institutional investment in cutting-edge devices.

Across Europe, the Middle East, and Africa, regulatory heterogeneity and varying reimbursement pathways create a mosaic of adoption rates. Western European nations with centralized health technology assessment processes have integrated ESD into standard care protocols for indicated lesions, whereas emerging markets within the region are actively building clinical infrastructure and training networks to bridge gaps in procedural expertise. Meanwhile, several Middle Eastern health systems are accelerating capital investments in specialized endoscopy units to position their centers at the forefront of GI oncology treatment.

The Asia-Pacific region continues to be a global leader in procedural innovation and clinical evidence generation, driven by high patient volumes and proactive government initiatives. Countries such as Japan and South Korea remain pioneers in technique refinement, while rapidly developing economies like India and China are scaling training programs and local device manufacturing capacities. Collaborative research consortia and public-private partnerships in the region are further expediting technology transfer and establishing new benchmarks for affordability and access.

Competitive Landscape and Strategic Movements of Leading Stakeholders Shaping the ESD Ecosystem

A cadre of global medtech leaders and specialized innovators defines the competitive contours of the endoscopic submucosal dissection market. Established incumbents are reinforcing their portfolios through incremental product enhancements, securing intellectual property for advanced knife geometries and ergonomic scope designs, and leveraging global distribution networks to broaden market penetration. Simultaneously, agile startups are gaining traction by introducing AI-assisted lesion detection software and next-generation insufflation technologies aimed at streamlining procedural workflows.

Strategic partnerships and collaborations between device manufacturers, academic centers, and contract research organizations have accelerated clinical validation pathways and enhanced regulatory readiness. Moreover, mergers and acquisitions remain a focal strategy for integrating complementary technologies and fortifying intellectual property pipelines. As these developments unfold, leading stakeholders are also prioritizing lifecycle management programs that include reusable component sterilization solutions, subscription-based service models, and digital health platforms designed to monitor post-procedural outcomes.

Overall, the competitive landscape is characterized by a dual imperative: advancing clinical performance while optimizing total cost of ownership. Organizations that successfully align product innovation, service excellence, and data-driven customer support are best positioned to capture value in an increasingly sophisticated ESD environment.

Proactive Strategies and Collaborative Initiatives to Propel Innovation, Market Penetration, and Sustainable Growth

To capitalize on the burgeoning opportunities in endoscopic submucosal dissection, industry leaders must emphasize cross-functional partnerships that bridge clinical, regulatory, and commercial expertise. Prioritizing investment in R&D for next-generation electrosurgical knives with adaptive feedback mechanisms will differentiate product offerings and address evolving clinical challenges. Concurrently, establishing comprehensive training ecosystems that integrate virtual reality simulators and certified proctorship ensures consistent procedural quality and shortens adoption curves for emerging markets.

Engaging with payers and health authorities to demonstrate the value proposition of ESD through real-world evidence and cost-effectiveness analyses will facilitate favorable reimbursement decisions and expand patient access. Diversifying supply chain networks by incorporating regional manufacturing hubs and strategic sourcing initiatives can mitigate tariff-related risks while optimizing inventory turnover. Furthermore, developing digital platforms for perioperative patient engagement and outcome tracking will foster data-driven improvements in clinical protocols and strengthen long-term customer loyalty.

Ultimately, aligning these strategies with sustainable business models-such as service-based agreements and outcome-based reimbursement schemes-will enhance market resilience. By adopting a holistic approach that balances innovation, education, and stakeholder alignment, organizations can secure a leadership position in the evolving ESD ecosystem.

Rigorous Multimodal Research Framework Integrating Primary Inquiry, Secondary Data, and Analytical Triangulation

The research underpinning this executive summary was conducted through a meticulous blend of primary and secondary methodologies. Key opinion leaders and endoscopy specialists were engaged in structured interviews and advisory workshops to capture nuanced perspectives on clinical workflows, technology adoption barriers, and unmet needs in endoscopic submucosal dissection. These qualitative insights were complemented by an extensive review of peer-reviewed journals, clinical trial registries, and conference proceedings to validate evolving best practices and emergent device performance data.

Secondary research included systematic analysis of regulatory filings, patent landscapes, and financial disclosures to map innovation trajectories and competitive positioning. Additionally, a detailed assessment of tariff schedules, reimbursement codes, and health technology assessment reports informed the evaluation of macroeconomic drivers. Quantitative data points were then subjected to triangulation against real-world procedural volumes and market intelligence sources to ensure consistency and reliability. The final deliverables underwent multiple iterations of peer review and methodological audits to confirm the integrity of findings and recommendations.

Synthesis of Core Insights and Future Trajectories to Empower Decision Makers and Foster Market Leadership

This executive summary has elucidated the intricate interplay of technological innovation, regulatory shifts, and market dynamics shaping the endoscopic submucosal dissection domain. Key takeaways underscore the critical impact of advanced knife designs, enhanced imaging modalities, and AI-driven decision support tools on procedural efficacy and safety. Simultaneously, the ramifications of tariff adjustments and evolving reimbursement landscapes necessitate agile sourcing strategies and proactive stakeholder engagement.

Looking ahead, the maturation of competency-based training programs, cross-border collaborations, and localized manufacturing initiatives will accelerate diffusion in underpenetrated markets. The integration of digital health platforms for patient monitoring and outcome analytics promises to refine clinical protocols and bolster evidence generation. As industry leaders align on sustainable business models and engage payers with compelling value narratives, endoscopic submucosal dissection is poised to become a standardized cornerstone of early gastrointestinal cancer management. Decision makers equipped with these insights are well-positioned to navigate complexity, drive innovation, and deliver superior patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Expansion of water-jet and hybrid knife technologies for faster and safer lesion dissection in ESD
  • 5.2. Adoption of artificial intelligence-driven lesion recognition systems in endoscopic submucosal dissection workflows
  • 5.3. Development of multifunctional endoscopic knives enabling simultaneous incision and hemostasis during ESD procedures
  • 5.4. Emergence of disposable endoscope platforms reducing cross-contamination risks in submucosal dissection treatments
  • 5.5. Integration of high-definition 3D imaging and augmented reality overlays for precision in ESD lesion targeting
  • 5.6. Growth of ESD training simulation programs employing virtual reality to accelerate physician proficiency in Asia-Pacific markets
  • 5.7. Partnerships between medical device manufacturers and academic centers for clinical validation of novel traction devices for ESD
  • 5.8. Regulatory approvals of next-generation endoscopic injection solutions enhancing submucosal lifting and procedural efficiency
  • 5.9. Rising utilization of traction-assisted ESD techniques using clip-and-line systems to reduce procedure time and complications
  • 5.10. Increase in reimbursement policies supporting outpatient endoscopic submucosal dissection procedures in developed healthcare systems

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Endoscopic Submucosal Dissection Market, by Product

  • 8.1. Introduction
  • 8.2. Accessory Devices
    • 8.2.1. Cap & Hood
    • 8.2.2. Forceps & Clips
    • 8.2.3. Injection Needles
    • 8.2.4. Insufflations Units
    • 8.2.5. Knives
      • 8.2.5.1. Dual
      • 8.2.5.2. Flex
      • 8.2.5.3. Hook
      • 8.2.5.4. Insulation-tipped
      • 8.2.5.5. Triangle-tipped
    • 8.2.6. Trocars
  • 8.3. Endoscopy Devices
    • 8.3.1. Colonoscopes
    • 8.3.2. Duodenoscopes
    • 8.3.3. Gastroscopes

9. Endoscopic Submucosal Dissection Market, by Procedure Type

  • 9.1. Introduction
  • 9.2. Full-Thickness Resection
  • 9.3. Hybrid ESD
  • 9.4. Partial-Thickness Resection

10. Endoscopic Submucosal Dissection Market, by Indication Type

  • 10.1. Introduction
  • 10.2. Colorectal Cancer
  • 10.3. Esophageal Cancer
  • 10.4. Gastric Cancer

11. Endoscopic Submucosal Dissection Market, by Disease Condition

  • 11.1. Introduction
  • 11.2. Benign Tumors
  • 11.3. Malignant Tumors
    • 11.3.1. Invasive
    • 11.3.2. Non-Invasive

12. Endoscopic Submucosal Dissection Market, by End-User Type

  • 12.1. Introduction
  • 12.2. Ambulatory Surgical Centers
  • 12.3. Hospitals
  • 12.4. Specialty Clinics

13. Americas Endoscopic Submucosal Dissection Market

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. Argentina

14. Europe, Middle East & Africa Endoscopic Submucosal Dissection Market

  • 14.1. Introduction
  • 14.2. United Kingdom
  • 14.3. Germany
  • 14.4. France
  • 14.5. Russia
  • 14.6. Italy
  • 14.7. Spain
  • 14.8. United Arab Emirates
  • 14.9. Saudi Arabia
  • 14.10. South Africa
  • 14.11. Denmark
  • 14.12. Netherlands
  • 14.13. Qatar
  • 14.14. Finland
  • 14.15. Sweden
  • 14.16. Nigeria
  • 14.17. Egypt
  • 14.18. Turkey
  • 14.19. Israel
  • 14.20. Norway
  • 14.21. Poland
  • 14.22. Switzerland

15. Asia-Pacific Endoscopic Submucosal Dissection Market

  • 15.1. Introduction
  • 15.2. China
  • 15.3. India
  • 15.4. Japan
  • 15.5. Australia
  • 15.6. South Korea
  • 15.7. Indonesia
  • 15.8. Thailand
  • 15.9. Philippines
  • 15.10. Malaysia
  • 15.11. Singapore
  • 15.12. Vietnam
  • 15.13. Taiwan

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Ambu A/S
    • 16.3.2. Beijing ZKSK Technology Co., Ltd.
    • 16.3.3. Boston Scientific Corporation
    • 16.3.4. ConMed Corporation
    • 16.3.5. Erbe Elektromedizin GmbH
    • 16.3.6. Fujifilm Holdings Corporation
    • 16.3.7. Hoya Corporation
    • 16.3.8. Huger Medical Instrument Co., Ltd.
    • 16.3.9. Interscope, Inc.
    • 16.3.10. Jiangsu Vedkang Medical Science and Technology Co., Ltd.
    • 16.3.11. Karl Storz SE & Co. KG
    • 16.3.12. Leo Medical Co. Ltd.
    • 16.3.13. Medi-Globe GmbH by DCC Healthcare
    • 16.3.14. Medtronic PLC
    • 16.3.15. Micro-Tech Endoscopy
    • 16.3.16. Mizuho America, Inc.
    • 16.3.17. MTW-Endoskopie W. Haag KG
    • 16.3.18. Olympus Corporation
    • 16.3.19. Ovesco Endoscope AG
    • 16.3.20. Richard Wolf GmbH
    • 16.3.21. SonoScape Medical Corp.
    • 16.3.22. Steris Corporation
    • 16.3.23. Zeon Medical Inc.
    • 16.3.24. Sumitomo Bakelite Co., Ltd.

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

  • FIGURE 1. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 16. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 18. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 24. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 25. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: RESEARCHAI
  • FIGURE 26. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: RESEARCHSTATISTICS
  • FIGURE 27. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: RESEARCHCONTACTS
  • FIGURE 28. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY CAP & HOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY CAP & HOOD, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FORCEPS & CLIPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FORCEPS & CLIPS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INJECTION NEEDLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INJECTION NEEDLES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INSUFFLATIONS UNITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INSUFFLATIONS UNITS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DUAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DUAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FLEX, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FLEX, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HOOK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HOOK, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INSULATION-TIPPED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INSULATION-TIPPED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY TRIANGLE-TIPPED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY TRIANGLE-TIPPED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY TROCARS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY TROCARS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COLONOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COLONOSCOPES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DUODENOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DUODENOSCOPES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GASTROSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GASTROSCOPES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FULL-THICKNESS RESECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FULL-THICKNESS RESECTION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HYBRID ESD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HYBRID ESD, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PARTIAL-THICKNESS RESECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PARTIAL-THICKNESS RESECTION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ESOPHAGEAL CANCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ESOPHAGEAL CANCER, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GASTRIC CANCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GASTRIC CANCER, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY BENIGN TUMORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY BENIGN TUMORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INVASIVE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY NON-INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY NON-INVASIVE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 86. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 87. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 88. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 89. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
  • TABLE 91. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 92. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 93. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 95. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025-2030 (USD MILLION)
  • TABLE 97. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025-2030 (USD MILLION)
  • TABLE 99. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2025-2030 (USD MILLION)
  • TABLE 101. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025-2030 (USD MILLION)
  • TABLE 103. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 105. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 106. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 107. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 108. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 109. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
  • TABLE 110. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
  • TABLE 111. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 112. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 113. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 114. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 115. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 116. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025-2030 (USD MILLION)
  • TABLE 117. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2024 (USD MILLION)
  • TABLE 118. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025-2030 (USD MILLION)
  • TABLE 119. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2024 (USD MILLION)
  • TABLE 120. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2025-2030 (USD MILLION)
  • TABLE 121. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2024 (USD MILLION)
  • TABLE 122. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025-2030 (USD MILLION)
  • TABLE 123. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 124. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 125. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 126. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 127. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 128. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 129. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
  • TABLE 130. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
  • TABLE 131. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 132. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 133. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 134. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 135. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025-2030 (USD MILLION)
  • TABLE 137. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2024 (USD MILLION)
  • TABLE 138. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025-2030 (USD MILLION)
  • TABLE 139. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2024 (USD MILLION)
  • TABLE 140. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2025-2030 (USD MILLION)
  • TABLE 141. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. CANADA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025-2030 (USD MILLION)
  • TABLE 143. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 144. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 145. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 146. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 147. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
  • TABLE 148. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
  • TABLE 149. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 150. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 151. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 153. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025-2030 (USD MILLION)
  • TABLE 155. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2024 (USD MILLION)
  • TABLE 156. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025-2030 (USD MILLION)
  • TABLE 157. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2024 (USD MILLION)
  • TABLE 158. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2025-2030 (USD MILLION)
  • TABLE 159. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. MEXICO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025-2030 (USD MILLION)
  • TABLE 161. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 162. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 163. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 164. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 165. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
  • TABLE 166. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
  • TABLE 167. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 168. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 169. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 171. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025-2030 (USD MILLION)
  • TABLE 173. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2024 (USD MILLION)
  • TABLE 174. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025-2030 (USD MILLION)
  • TABLE 175. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2024 (USD MILLION)
  • TABLE 176. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2025-2030 (USD MILLION)
  • TABLE 177. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. BRAZIL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025-2030 (USD MILLION)
  • TABLE 179. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 180. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 181. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 182. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 183. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
  • TABLE 184. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
  • TABLE 185. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 186. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 187. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 189. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025-2030 (USD MILLION)
  • TABLE 191. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2024 (USD MILLION)
  • TABLE 192. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025-2030 (USD MILLION)
  • TABLE 193. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2024 (USD MILLION)
  • TABLE 194. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2025-2030 (USD MILLION)
  • TABLE 195. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. ARGENTINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2025-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 217. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 218. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 219. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 220. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 221. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
  • TABLE 222. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
  • TABLE 223. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 224. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 225. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2024 (USD MILLION)
  • TABLE 230. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2024 (USD MILLION)
  • TABLE 232. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2025-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. UNITED KINGDOM ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025-2030 (USD MILLION)
  • TABLE 235. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 236. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 237. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 238. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 239. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
  • TABLE 240. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
  • TABLE 241. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 242. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 243. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 245. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025-2030 (USD MILLION)
  • TABLE 247. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2024 (USD MILLION)
  • TABLE 248. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025-2030 (USD MILLION)
  • TABLE 249. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2024 (USD MILLION)
  • TABLE 250. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2025-2030 (USD MILLION)
  • TABLE 251. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. GERMANY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025-2030 (USD MILLION)
  • TABLE 253. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 254. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 255. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 256. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 257. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
  • TABLE 258. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
  • TABLE 259. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 260. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 261. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 263. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025-2030 (USD MILLION)
  • TABLE 265. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2024 (USD MILLION)
  • TABLE 266. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025-2030 (USD MILLION)
  • TABLE 267. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2024 (USD MILLION)
  • TABLE 268. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2025-2030 (USD MILLION)
  • TABLE 269. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. FRANCE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025-2030 (USD MILLION)
  • TABLE 271. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 272. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 273. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 274. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 275. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
  • TABLE 276. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
  • TABLE 277. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 278. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 279. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 281. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025-2030 (USD MILLION)
  • TABLE 283. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2024 (USD MILLION)
  • TABLE 284. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025-2030 (USD MILLION)
  • TABLE 285. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2024 (USD MILLION)
  • TABLE 286. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2025-2030 (USD MILLION)
  • TABLE 287. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. RUSSIA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025-2030 (USD MILLION)
  • TABLE 289. ITALY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 290. ITALY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 291. ITALY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 292. ITALY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 293. ITALY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2024 (USD MILLION)
  • TABLE 294. ITALY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2025-2030 (USD MILLION)
  • TABLE 295. ITALY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 296. ITALY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 297. ITALY ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET